KLN Selected by Teva as its Exclusive 4PL Service Provider in the Greater Bay Area
HONG KONG, March 13, 2025 /PRNewswire/ -- Kerry Logistics Network Limited ('KLN'; Stock Code 0636.HK), through its subsidiary, Kerry Pharma, and Teva Pharmaceutical Hong Kong Limited ('Teva') entered into an exclusive agreement for fourth-party...
Visionary Enters the New Energy Vehicle Field with Eyes on the Global Market
TORONTO, March 3, 2025 /PRNewswire/ -- Recently, Visionary Holdings Inc. (hereinafter referred to as "Visionary", NASDAQ stock code: GV), a technology enterprise listed on the NASDAQ Capital Market, announced that after years of research and...
Autohome Inc. Announces Change in Controlling Shareholder and Management Change
BEIJING, Feb. 20, 2025 /PRNewswire/ -- Autohome Inc. (NYSE: ATHM; HKEX: 2518) ("Autohome" or the "Company"), the leading online destination for automobile consumers in China, today announced that the Company has been informed by Yun Chen Capital...
Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Serplulimab is the world's first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC Serplulimab is the first and only anti-PD-1 mAb approved in the European Union (EU) for the treatment of ES-SCLC Serplulimab has now...
Cyient and Micware Navigations Forge Strategic Alliance to Shape the Future of Mobility
HYDERABAD, India, Feb. 5, 2025 /PRNewswire/ -- Cyient, a global Intelligent Engineering services company, announced that it entered into a memorandum of understanding with Micware Navigations, a leader in navigation and mobility services. As per the...
Harbour BioMed Receives NMPA IND Clearance for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Feb. 5, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody...
YCH Group and Sime Darby Property Form Strategic Collaboration to Explore Logistics Infrastructure
GEORGETOWN, Malaysia, Jan. 17, 2025 /PRNewswire/ -- On 16 January 2025, Singapore's leading logistics and supply chain company, YCH Group, has entered into a strategic partnership with Malaysia's premier property developer, Sime Darby Property...
Senaparib Approved by NMPA for 1L Maintenance Therapy in Ovarian Cancer
SHANGHAI, Jan. 17, 2025 /PRNewswire/ -- IMPACT Therapeutics ("IMPACT"), a biopharmaceutical company focusing on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality, is pleased to announce that Senaparib...
Telix Exceeds FY24 Guidance with US$142M Q4 Revenue
MELBOURNE, Australia and INDIANAPOLIS, Jan. 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today provides an update on its commercial and operational performance for the quarter ended 31 December...
Scintimun® Commercialization Partnership with Curium Pharma
MELBOURNE, Australia and LIÈGE, Belgium, Jan. 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has entered into an agreement with Curium Pharma for the transfer of marketing...